Physician

Michelle Leigh Myers, D.O.

According to 2025 Medicare claims, Michelle Myers, D.O. (NPI: 1962533083) practices nephrology in the Twin Falls, ID market, with the plurality of this provider's patient population coming from Twin Falls, ID. This provider's primary affiliated billing organization is ST LUKE'S CLINIC LLC (NPI: 1790718229; TIN: 45-2716222) and primary practice location at 83301-3042. Myers is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), MountainStar Care Partners ACO (ACO ID: A5181), and St. Luke's Clinic Coordinated Care, Ltd (ACO ID: D0059), participating under both the MSSP and REACH models.

Myers' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 282 traditional Medicare patients, billed 883 HCPCS/CPT codes, and received $103,584 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 2,005 prescription claims across 335 beneficiaries totaling $150,482 in drug costs, led by Jardiance (Empagliflozin). DME data shows 815 claims. Open Payments data shows 1 records totaling $13. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $112,027 and ending at $103,584. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $267,287 to $150,482. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	313	1,155	$112,027
2016	296	954	$90,360
2017	334	1,203	$106,925
2018	355	1,213	$110,334
2019	453	1,607	$162,921
2020	403	1,463	$156,443
2021	341	1,175	$116,692
2022	390	1,236	$168,765
2023	366	1,114	$150,212
2024	282	883	$103,584

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	226	2,471	$267,287
2016	197	2,130	$262,281
2017	225	2,011	$314,647
2018	260	1,923	$199,202
2019	304	1,986	$149,849
2020	331	2,206	$143,487
2021	293	1,985	$105,948
2022	329	2,077	$108,066
2023	375	2,222	$142,581
2024	335	2,005	$150,482

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	161	$5,709
2016	N/R	225	$7,779
2017	N/R	161	$5,725
2018	N/R	161	$7,546
2019	N/R	102	$2,893
2020	N/R	125	$2,986
2021	23	378	$19,722
2022	30	555	$25,713
2023	64	776	$25,744
2024	47	815	$28,522

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	44	172	$258
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	30	40	$215
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	39	43	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	184	401	$63
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	37	95	$56

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	22	1,620	$31,136
Eliquis	Apixaban	23	1,350	$25,001
Farxiga	Dapagliflozin Propanediol	24	1,316	$24,045
Auryxia	Ferric Citrate	13	390	$13,276
Sevelamer Carbonate	Sevelamer Carbonate	49	2,018	$9,979

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7527	Everolimus, oral, 0.25 mg	N	N/R	15	$7,322
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	35	$6,810
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	81	$4,236
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	18	240	$2,959
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	18	154	$2,804

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$13	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michelle Leigh Myers, D.O.?

Tedicare shows public-source Medicare data for Michelle Leigh Myers, D.O. (NPI 1962533083), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michelle Leigh Myers, D.O. have ACO affiliation data?

Michelle Leigh Myers, D.O. is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), MountainStar Care Partners ACO (MSSP, ACO ID A5181), and St. Luke's Clinic Coordinated Care, Ltd (REACH, ACO ID D0059).

What billing organization is linked to Michelle Leigh Myers, D.O.?

Michelle Leigh Myers, D.O. is linked to ST LUKE'S CLINIC LLC (billing NPI 1790718229) in the available physician profile data.

Does Michelle Leigh Myers, D.O. have Open Payments data?

Michelle Leigh Myers, D.O. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.